Sirtratumab Biosimilar - Research Grade

Human

SLITRK6ï؟½

5mg/ml

IgG2 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q9H5Y7

Blue ice

SLITRK6 is a transmembrane protein expressed in certain epithelial tumors, including urothelial carcinoma, and is studied as a tumor-targeting antigen. Described here is a research-grade, unconjugated analog of sirtratumab, a recombinant anti-SLITRK6 monoclonal antibody for research use only. It is produced to in vivo standards with low endotoxin and supplied in scalable milligram to gram quantities for high-throughput programs. The antibody supports antigen-binding functional assays, in vitro tumor-cell screening, and in vivo targeting models within oncology research. Dependable lot-to-lot consistency underpins reliable use across large and repeated experiments. Its reproducible formulation and scalable volumes support standardized results in bulk research.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks